Anaxomics maps have been presented in the cover page of the November issue of Nature Chemical Biology

Home > Services

Services


1. For Bio-Pharma Companies:


Drug reprofiling:

Finding new indications for existing drugs.
We help our customers to reprofile existing products in their pipeline, by developing a product lifecycle extension program.



Safety Analysis and Early profiling of safety issues and off-target effects

Bio-pharma companies need a better understanding of the AE profile of a compound of interest. We will provide you with an unique and in-depth analysis of the Aes profile of your compound.



In and out-licensing:
Take the correct decisions

Our goal is to help you take the correct decisions in in / out licensing your products by correctly evaluating the efficacy potential and the safety profile.



Required regulatory
Predictive Medicine studies

FDA and EMEA are emphasizing the importance of understanding the molecular and physiological basis of therapies by using the new tools of Predictive Medicine. We will help you comply these regulatory requirements.

2. For Nutraceuticals and Cosmetics:

Scientific Fundamentals

Learn how we can help you sustain your scientific claims in front of regulatory agencies and the public and explain the mechanisms of action.




We also stablish long-term strategic partnerships with our clients to:

  • Identify new drug targets
  • Identify new Biomarkers
  • Identify mechanisms of action


  • Business cases

    Read our business cases, to understand how Anaxomics can really help you add value to your discovery

  • News

    Anaxomics to be
    present at Chicago
    2010 Bio International Convention May 3-6

  • Contact

    Judith Farrés
    PhD, MSc
    info@anaxomics.com Tel:  +34 934 516 717
    Cell: +34 610 742 196

  • Careers

    Anaxomics offers positions for professionals who love working for a cutting-edge consultancy firm in a multinational environment.